Evofem Biosciences Inc. sell me8
Start price
28.06.22
/
0%
€1.18
Target price
28.06.23
-
Performance (%)
-34.12%
End price
29.06.22
€0.78
Summary
This prediction ended on 29.06.22 with a price of €0.78. The SELL prediction by me8 for Evofem Biosciences Inc. performed very well with a performance of -34.12%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Evofem Biosciences Inc. | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% |
According to me8 what are the pros and cons of Evofem Biosciences Inc. for the foreseeable future?
Pros
Good culture
Cons
Risky Investment
No Innovation
Comments by me8 for this prediction
In the thread Evofem Biosciences diskutieren
Sell Evofem Biosciences Inc.